Clearside Biomedical Stock Investor Sentiment

CLSD Stock  USD 0.86  0.03  3.37%   
About 63% of all Clearside Biomedical's shareholders are looking to take a long position. The analysis of overall sentiment of trading Clearside Biomedical stock suggests that some investors are interested at this time. The current market sentiment, together with Clearside Biomedical's historical and current headlines, can help investors time the market. In addition, many technical investors use Clearside Biomedical stock news signals to limit their universe of possible portfolio assets.

Comfort Level 63

 Interested

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Clearside Biomedical's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Clearside Biomedical.

Clearside Historical Sentiment

Although Clearside Biomedical's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Clearside, such as negative comments on social media and news outlets, may cause fear in the market and push Clearside Biomedical's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Clearside.
  

Clearside Biomedical Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Clearside Biomedical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over three months ago at globenewswire.com         
Clearside Biomedicals Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighte...
Macroaxis News: globenewswire.com
over three months ago at thelincolnianonline.com         
Clearside Biomedical Price Target Increased to 6.00 by Analysts at Needham Company LLC
news
over three months ago at seekingalpha.com         
Clearside stock falls 12 percent amid Phase 2 data for CLS-AX
seekingalpha News
over three months ago at benzinga.com         
Clearside Biomedicals Investigational Drug For Vision Loss Hits Primary Goals In Mid-Stage Study
benzinga news
over three months ago at globenewswire.com         
Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroida...
Macroaxis News: globenewswire.com
over three months ago at finance.yahoo.com         
Clearside Biomedicals Investigational Drug For Vision Loss Hits Primary Goals In Mid-Stage Study
Yahoo News
over three months ago at news.google.com         
Armistice Capital LLC Decreases Position in Clearside Biomedical, Inc. - MarketBeat
Google News at Macroaxis
over six months ago at www.macroaxis.com         
Acquisition by Gibney Anthony S of 45000 shares of Clearside Biomedical at 1.29 subject to Rule 16b-...
Macroaxis News
over six months ago at globenewswire.com         
Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CL...
Macroaxis News: globenewswire.com
over six months ago at news.google.com         
Clearside Biomedical Research Coverage Started at Chardan Capital - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Clearside Biomedical Stock Price, News Analysis - MarketBeat
Google News at Macroaxis
over six months ago at zacks.com         
After Plunging -15.7 percent in 4 Weeks, Heres Why the Trend Might Reverse for Clearside Biomedical
zacks News
over six months ago at finance.yahoo.com         
After Plunging -15.7 percent in 4 Weeks, Heres Why the Trend Might Reverse for Clearside Biomedical
Yahoo News
over six months ago at simplywall.st         
Clearside Biomedical Second Quarter 2024 Earnings EPS Beats Expectations, Revenues Lag
Simply Wall St News at Macroaxis
over six months ago at investorplace.com         
CLSD Stock Earnings Clearside Biomedical Beats EPS, Misses Revenue for Q2 2024
sbwire news
Far too much social signal, news, headlines, and media speculation about Clearside Biomedical that are available to investors today. That information is available publicly through Clearside media outlets and privately through word of mouth or via Clearside internal channels. However, regardless of the origin, that massive amount of Clearside data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Clearside Biomedical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Clearside Biomedical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Clearside Biomedical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Clearside Biomedical alpha.

Clearside Biomedical Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Heres Why Clearside Biomedical Is a Great Buy the Bottom Stock Now
12/12/2024
2
Analyst Sees 500 percent Upside for This Pharmaceutical Penny Stock
12/20/2024
3
Acquisition by Lasezkay George M of 500000 shares of Clearside Biomedical at 0.97 subject to Rule 16b-3
01/08/2025
4
Clearside Biomedical Announces its Asia-Pacific Partner, Arctic Vision, Received Approval of Suprachoroidal Treatment for Uveitic Macular Edema in Australia and...
01/22/2025
5
Clearside Biomedical Announces Multiple Medical Meeting Presentations Focused on the Advantages of Suprachoroidal Delivery andKey Differentiators in its CLS-AX ...
01/28/2025
6
Acquisition by Yerxa Benjamin R of 7813 shares of Clearside Biomedical at 1.31 subject to Rule 16b-3
02/14/2025
7
Clearside Biomedicals Asia-Pacific Partner, Arctic Vision, Announced Acceptance of its New Drug Application for ARCATUS for Regulatory Review in China for the T...
02/20/2025
8
Acquisition by Thorp Clay of 15000 shares of Clearside Biomedical at 0.92 subject to Rule 16b-3
02/24/2025
9
Insider Buying Clearside Biomedical, Inc. Director Acquires 15,000 Shares of Stock
02/25/2025

Complementary Tools for Clearside Stock analysis

When running Clearside Biomedical's price analysis, check to measure Clearside Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearside Biomedical is operating at the current time. Most of Clearside Biomedical's value examination focuses on studying past and present price action to predict the probability of Clearside Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearside Biomedical's price. Additionally, you may evaluate how the addition of Clearside Biomedical to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Stocks Directory
Find actively traded stocks across global markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets